Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions

被引:14
作者
English, Andrew [1 ]
Irwin, Nigel [1 ]
机构
[1] Ulster Univ, Sch Pharm & Pharmaceut Sci, Coleraine BT52 1SA, Londonderry, North Ireland
关键词
beta-cell; insulin secretion; nonclassical islet peptides; dual agonist; triagonist; GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; GASTRIC-INHIBITORY POLYPEPTIDE; NUCLEUS-TRACTUS-SOLITARIUS; TRIPLE-ACTING AGONIST; BETA-CELL FUNCTION; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; HYBRID PEPTIDE; NEUROPEPTIDE-Y;
D O I
10.1177/1179551419888871
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The pancreas has physiologically important endocrine and exocrine functions; secreting enzymes into the small intestine to aid digestion and releasing multiple peptide hormones via the islets of Langerhans to regulate glucose metabolism, respectively. Insulin and glucagon, in combination with ghrelin, pancreatic polypeptide and somatostatin, are the main classical islet peptides critical for the maintenance of blood glucose. However, pancreatic islets also synthesis numerous 'nonclassical' peptides that have recently been demonstrated to exert fundamental effects on overall islet function and metabolism. As such, insights into the physiological relevance of these nonclassical peptides have shown impact on glucose metabolism, insulin action, cell survival, weight loss, and energy expenditure. This review will focus on the role of individual nonclassical islet peptides to stimulate pancreatic islet secretions as well as regulate metabolism. In addition, the more recognised actions of these peptides on satiety and energy regulation will also be considered. Furthermore, recent advances in the field of peptide therapeutics and obesity-diabetes have focused on the benefits of simultaneously targeting several hormone receptor signalling cascades. The potential for nonclassical islet hormones within such combinational approaches will also be discussed.
引用
收藏
页数:10
相关论文
共 149 条
[1]   GLP-1: physiological effects and potential therapeutic applications [J].
Aaboe, Kasper ;
Krarup, Thure ;
Madsbad, Sten ;
Holst, Jens Juul .
DIABETES OBESITY & METABOLISM, 2008, 10 (11) :994-1003
[2]   Signals in the pancreatic islet microenvironment influence -cell proliferation [J].
Aamodt, Kristie I. ;
Powers, Alvin C. .
DIABETES OBESITY & METABOLISM, 2017, 19 :124-136
[3]   Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes [J].
Ahrén, B ;
Holst, JJ ;
Efendic, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1043-1048
[4]   MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study [J].
Ambery, Philip ;
Parker, Victoria E. ;
Stumvoll, Michael ;
Posch, Maximilian G. ;
Heise, Tim ;
Plum-Moerschel, Leona ;
Tsai, Lan-Feng ;
Robertson, Darren ;
Jain, Meena ;
Petrone, Marcella ;
Rondinone, Cristina ;
Hirshberg, Boaz ;
Jermutus, Lutz .
LANCET, 2018, 391 (10140) :2607-2618
[5]   MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subject, randomized, Phase 1 study [J].
Ambery, Philip D. ;
Klammt, Sebastian ;
Posch, Maximillian G. ;
Petrone, Marcella ;
Pu, Wenji ;
Rondinone, Cristina ;
Jermutus, Lutz ;
Hirshberg, Boaz .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (10) :2325-2335
[6]   Ghrelin-producing epsilon cells in the developing and adult human pancreas [J].
Andralojc, K. M. ;
Mercalli, A. ;
Nowak, K. W. ;
Albarello, L. ;
Calcagno, R. ;
Luzi, L. ;
Bonifacio, E. ;
Doglioni, C. ;
Piemonti, L. .
DIABETOLOGIA, 2009, 52 (03) :486-493
[7]   Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide [J].
Astrup, A. ;
Carraro, R. ;
Finer, N. ;
Harper, A. ;
Kunesova, M. ;
Lean, M. E. J. ;
Niskanen, L. ;
Rasmussen, M. F. ;
Rissanen, A. ;
Rossner, S. ;
Savolainen, M. J. ;
Van Gaal, L. .
INTERNATIONAL JOURNAL OF OBESITY, 2012, 36 (06) :843-854
[8]   Hormonal Regulators of Appetite [J].
Austin, Juliana ;
Marks, Daniel .
INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2009,
[9]   NEUROTENSIN AND OXYNTOMODULIN-(30-37) POTENTIATE PYY REGULATION OF GASTRIC-ACID AND SOMATOSTATIN SECRETIONS [J].
BADO, A ;
CLOAREC, D ;
MOIZO, L ;
LAIGNEAU, JP ;
BATAILLE, D ;
LEWIN, MJM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01) :G113-G117
[10]   Biology of incretins: GLP-1 and GIP [J].
Baggio, Laurie L. ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2007, 132 (06) :2131-2157